• Our Services

    We offer best-in-class research and consulting services pertaining to the markets of all geographies. Our experienced team of business analysts and consultants has mastered fundamental and advanced market research in diverse industries.

  • Syndicated Research

    Syndicated research is the most cost-effective market research approach, which gives an analytical outlook of the competitive positioning, product positioning, and size estimation of the market at the micro level. Our off-the-shelf reports offer key market insights that industry stakeholders require to base their business strategy on. Our syndicated research services empower our clients to meet diverse market objectives.

  • Customized Research

    we also deliver customized research services to address specific needs of our clients. With a vast pool of adroit analysts who are proficient in market research, we take pride in tailoring our research services to meet our clients’ definite requirements and aid their business growth.

  • Consulting Services

    Businesses, today, need to adapt themselves to the changes that transpire in the market. Staying abreast of the market trends, therefore, becomes imperative for accomplishing business objectives.

  • Our Vision

    To be the most trusted partner in our clients' success endeavors

Showing posts with label Hyperphosphatemia Therapeutics - Pipeline Analysis. Show all posts
Showing posts with label Hyperphosphatemia Therapeutics - Pipeline Analysis. Show all posts

Hyperphosphatemia Therapeutics - Pipeline Analysis , Clinical Trials & Results


Hyperphosphatemia is a medical condition which involves increased level of serum phosphate concentration in the blood. Phosphate is required for bone and cell formation, genetic coding and energy metabolism.

Access More About This Research at:


An individual is said to have hyperphosphatemia, if the phosphate concentration increasing beyond > 4.5 mg/dL (> 1.46 mmol/L).  Similar to calcium, vitamin D is required to properly absorb phosphate. The various causes of hyperphosphatemia include excessive intake of phosphate, inadequate excretion of phosphates, hypothyroidism, high vitamin D levels, and injuries causing muscle damage.

Request to Get the Sample Pages at: 
                                                        https://www.pharmaproff.com/request-sample/1138

Signs and symptoms associated with the hyperphosphatemia include renal osteodystrophy, secondary hyperparathyroidism and ectopic calcification. Hyperphosphatemia can be treated with phosphate binders, vitamin D analogs, and dietary restriction of phosphate.

Chugai Pharmaceutical Co. Ltd. is developing EOS789 as an oral formulation for the treatment of hyperphosphatemia. Some of the other companies developing hyperphosphatemia therapeutics include Ardelyx Inc., and OPKO Health Inc.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Share:

Profile

Popular Posts

APSense

Labels

Linkedin Profile

APSense

Business Network

Recent Posts

Research Pages